Vaccitech, startup behind Oxford's COVID-19 vaccine, files for US IPO

Biotech startup Vaccitech Plc, which owns the technology behind the COVID-19 vaccine developed by Oxford University and AstraZeneca Plc, filed for a US initial public offering.